Compare RVSN & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RVSN | VNRX |
|---|---|---|
| Founded | 2016 | N/A |
| Country | Israel | United States |
| Employees | 47 | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9M | 18.9M |
| IPO Year | N/A | 2012 |
| Metric | RVSN | VNRX |
|---|---|---|
| Price | $4.88 | $3.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $1.67 |
| AVG Volume (30 Days) | 20.1K | ★ 347.4K |
| Earning Date | 03-31-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,727,384.00 |
| Revenue This Year | $860.32 | $355.66 |
| Revenue Next Year | N/A | $849.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40.04 |
| 52 Week Low | $0.17 | $0.13 |
| 52 Week High | $9.39 | $3.26 |
| Indicator | RVSN | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 21.48 | 77.26 |
| Support Level | $0.31 | $0.22 |
| Resistance Level | $9.07 | N/A |
| Average True Range (ATR) | 0.38 | 0.28 |
| MACD | -0.20 | 0.01 |
| Stochastic Oscillator | 6.35 | 94.09 |
Rail Vision Ltd is an early commercialization stage technology company focused on railway safety systems using AI-integrated sensing systems. The company develops and commercializes proprietary, multi-spectral electro-optic platforms that provide extended-range situational awareness and real-time hazard detection. Using machine learning algorithms to identify and classify obstacles, the company's technology enhances safety, improves operational efficiency, and supports continuity across deployments.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.